TRANSITION FROM INTRAVENOUS TO SUBCUTANEOUS INFLIXIMAB AND VEDOLIZUMAB: ADHERENCE, SATISFACTION AND SAFETY PROFILE IN A COHORT OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE
Alessia Todeschini 1
Andrea Geccherle 1
Paola Signoretto 1
Giuliano Barugola 1
Angela Variola 1
1 IRCCS Sacro Cuore Don Calabria, Negrar di Valpolicella, Italy
Topic
IBD
Session
PP 05 IBD (Posters)
Conference
UEG Week 2023
Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]